INTERNATIONAL BIOTECHNOLOGY TRUST PLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$939,400
-41.6%
20,000
-7.0%
0.29%
-32.9%
Q1 2021$1,609,000
+2.5%
21,500
-42.8%
0.43%
-18.4%
Q2 2020$1,570,000
+45.8%
37,6000.0%0.52%
+6.3%
Q1 2020$1,077,000
-63.9%
37,600
-9.2%
0.49%
-54.3%
Q4 2019$2,983,000
+32.9%
41,400
+158.8%
1.08%
+3.7%
Q3 2019$2,245,000
-63.9%
16,000
-52.9%
1.04%
-55.1%
Q2 2019$6,224,000
+15.1%
33,9960.0%2.31%
+15.5%
Q1 2019$5,407,000
+349.5%
33,996
+112.5%
2.00%
+167.5%
Q4 2018$1,203,000
-30.5%
15,9960.0%0.75%
-9.2%
Q3 2018$1,732,000
-74.2%
15,996
-62.8%
0.82%
-68.1%
Q2 2018$6,726,000
-40.7%
42,996
-39.0%
2.58%
-41.6%
Q1 2018$11,346,000
+33.8%
70,496
+36.9%
4.43%
+48.0%
Q4 2017$8,481,000
+700.8%
51,496
+203.0%
2.99%
+625.7%
Q3 2017$1,059,000
-21.7%
16,9960.0%0.41%
-19.8%
Q2 2017$1,353,000
+12.0%
16,9960.0%0.51%
+11.3%
Q1 2017$1,208,000
+39.3%
16,9960.0%0.46%
+18.2%
Q4 2016$867,00016,9960.39%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders